A detailed history of Constitution Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Constitution Capital LLC holds 1,200 shares of VRTX stock, worth $541,164. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,200
Previous 1,050 14.29%
Holding current value
$541,164
Previous $492,000 13.41%
% of portfolio
0.3%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$460.0 - $505.78 $69,000 - $75,867
150 Added 14.29%
1,200 $558,000
Q1 2024

Apr 15, 2024

BUY
$407.69 - $446.08 $428,074 - $468,384
1,050 New
1,050 $438,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Constitution Capital LLC Portfolio

Follow Constitution Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Constitution Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Constitution Capital LLC with notifications on news.